共 4 条
[1]
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial[J] Esler Murray D;Krum Henry;Sobotka Paul A;Schlaich Markus P;Schmieder Roland E;Böhm Michael The Lancet 2010,
[2]
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J] Henry Krum;Markus Schlaich;Rob Whitbourn;Paul A Sobotka;Jerzy Sadowski;Krzysztof Bartus;Boguslaw Kapelak;Anthony Walton;Horst Sievert;Suku Thambar;William T Abraham;Murray Esler The Lancet 2009,
[3]
Endothelin as a Clinical Target in the Treatment of Systemic Hypertension[J] Vinoy S. Prasad;Chandrasekar Palaniswamy;William H. Frishman Cardiology in Review 2009,
[4]
Resistant Hypertension: Diagnosis; Evaluation; and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J] David A. Calhoun;Daniel Jones;Stephen Textor;David C. Goff;Timothy P. Murphy;Robert D. Toto;Anthony White;William C. Cushman;William White;Domenic Sica;Keith Ferdinand;Thomas D. Giles;Bonita Falkner;Robert M. Carey Hypertension 2008,